These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Current advances in the translation of vascular tissue engineering to the treatment of pediatric congenital heart disease. Dean EW; Udelsman B; Breuer CK Yale J Biol Med; 2012 Jun; 85(2):229-38. PubMed ID: 22737051 [TBL] [Abstract][Full Text] [Related]
10. A clinical commentary on the article "an early study on the mechanisms that allow tissue-engineered vascular grafts to resist intimal hyperplasia". Shenoy S J Cardiovasc Transl Res; 2011 Oct; 4(5):683-4. PubMed ID: 21842342 [No Abstract] [Full Text] [Related]
11. Risk factors for distal Contegra stenosis: results of a prospective European multicentre study. Boethig D; Schreiber C; Hazekamp M; Blanz U; Prêtre R; Asfour B; Greco R; Alexi-Meskishvili V; Gonçalves A; Breymann T Thorac Cardiovasc Surg; 2012 Apr; 60(3):195-204. PubMed ID: 22228091 [TBL] [Abstract][Full Text] [Related]
14. Transcatheter valve implantation for right atrium-to-right ventricle conduit obstruction or regurgitation after modified Björk-fontan procedure. Shah AH; Horlick EM; Eicken A; Asnes JD; Bocks ML; Boudjemline Y; Cabalka AK; Fagan TE; Schubert S; Mahadevan VS; Dvir D; Osten M; McElhinney DB Catheter Cardiovasc Interv; 2017 Feb; 89(2):298-305. PubMed ID: 27465501 [TBL] [Abstract][Full Text] [Related]
15. Experience and intermediate-term results using the Contegra heterograft for right ventricular outflow reconstruction in adults. Niclauss L; Delay D; Hurni M; von Segesser LK Interact Cardiovasc Thorac Surg; 2009 Oct; 9(4):667-71. PubMed ID: 19638357 [TBL] [Abstract][Full Text] [Related]
16. Off-label use of stretchable polytetrafluoroethylene: overexpansion of synthetic shunts. Verbelen TO; Famaey N; Gewillig M; Rega FR; Meyns B Int J Artif Organs; 2010 May; 33(5):263-70. PubMed ID: 20593347 [TBL] [Abstract][Full Text] [Related]
17. Vascular grafts and valves that animate, made from decellularized biologically-engineered tissue tubes. Syedain ZH; Maciver R; Tranquillo RT J Cardiovasc Surg (Torino); 2020 Oct; 61(5):577-585. PubMed ID: 32964902 [TBL] [Abstract][Full Text] [Related]
18. The applications of heparin in vascular tissue engineering. Aslani S; Kabiri M; HosseinZadeh S; Hanaee-Ahvaz H; Taherzadeh ES; Soleimani M Microvasc Res; 2020 Sep; 131():104027. PubMed ID: 32505610 [TBL] [Abstract][Full Text] [Related]
19. Electrospinning of biomimetic scaffolds for tissue-engineered vascular grafts: threading the path. Woods I; Flanagan TC Expert Rev Cardiovasc Ther; 2014 Jul; 12(7):815-32. PubMed ID: 24903895 [TBL] [Abstract][Full Text] [Related]
20. Vascular tissue engineering: towards the next generation vascular grafts. Naito Y; Shinoka T; Duncan D; Hibino N; Solomon D; Cleary M; Rathore A; Fein C; Church S; Breuer C Adv Drug Deliv Rev; 2011 Apr; 63(4-5):312-23. PubMed ID: 21421015 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]